Clonal selection for transcriptionally active viral oncogenes during progression to cancer

Journal of Virology

Volumn 78, Issue 20, 2004, Pages 11172-11186

  Van Tine, Brian A ^a,b   Kappes, John C ^c,d   Banerjee, N Sanjib ^b   Knops, Judith ^e,i   Lai, Lilin ^c   Steenbergen, Renske D M ^f   Meijer, Chris L J M ^f   Snijders, Peter J F ^f   Chatis, Pamela ^g,h   Broker, Thomas R ^b   Moen Jr , Phillip T ^g,j   Chow, Louise T ^b,e  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g PERKINELMER INC   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ GENZYME GENETICS   (United States)

^j One Cell Systems Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; VIRUS DNA;

ARTICLE; CANCER GROWTH; CANCER TISSUE; CELL IMMORTALIZATION; CELL LINE; CELL SURVIVAL; CHROMOSOME 14; CONTROLLED STUDY; DNA INTEGRATION; DNA METHYLATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MARKER GENE; MOLECULAR CLONING; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS ONCOGENE; VIRUS TRANSCRIPTION; WART VIRUS;

CELL LINE, TRANSFORMED; CELL NUCLEOLUS; CELL TRANSFORMATION, NEOPLASTIC; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RNA, VIRAL; SELECTION (GENETICS); TRANSCRIPTION, GENETIC; TYRAMINE; VIRUS INTEGRATION;

EID: 4644332773     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.20.11172-11186.2004     Document Type: Article

References (73)

1. Adler, K., K. T. Erickson, and M. Bobrow. 1997. High sensitivity detection of HPV-16 in SiHa and CaSki cells using FISH enhanced by TSA. Histochem. Cell Biol. 108:321-324.
2. Badal, V., L. S. H. Chuang, E. H.-H. Tan, S. Badal, L. L. Villa, C. M. Wheeler, B. F. L. Li, and H.-U. Bernard. 2003. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 77:6227-6234.
3. Baker, C. C., W. C. Phelps, V. Lindgren, M. J. Braun, M. A. Gonda, and P. M. Howley. 1987. Structural and transcriptional analysis of human papillomavirus 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
4. Bobrow, M. N., and P. T. Moen. 2000. Tyramide signal amplification (TSA) systems for the enhancement of ISH signals in cytogenetics, In J. P. Robinson (ed.), Current protocols in cytometry. John Wiley & Sons, Inc., New York, N.Y.
5. Burnett, T. S., and P. H. Gallimore. 1985. Introduction of cloned human papillomavirus 1a DNA into rat fibroblasts: integration, de novo methylation and absence of cellular morphological transformation. J. Gen. Virol. 66: 1063-1072.
6. Cahill, D. P., K. W. Kinzler, B. Vogelstein, and C. Lengauer. 1999. Genetic instability and Darwinian selection in tumours. Trends Cell Biol. 9:M57-M60.
7. Chen, W., X. Wu, D. N. Levasseur, H. Liu, L. Lai, J. C. Kappes, and T. M. Townes. 2000. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18:352-359.
8. Cheng, S., D.-C. Schmidt-Grimminger, T. Murant, T. R. Broker, and L. T. Chow. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349.
9. Chin, M. T., T. R. Broker, and L. T. Chow. 1989. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation. J. Virol. 63: 2967-2976.
10. Chow, L. T., and T. R. Broker. 1997. Small DNA tumor viruses, In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa. p. 267-302.
11. Chow, L. T., M. Nasseri, S. M. Wolinsky, and T. R. Broker. 1987. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61:2581-2588.
12. Crum, C. P., G. Nuovo, D. Friedman, and S. J. Silverstein. 1988. Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J. Virol. 62:84-90.
13. Curradi, M., A. Izzo, G. Badaracco, and N. Landsberger. 2002. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol. 22:3157-3173.
14. DeFilippis, R. A., E. C. Goodwin, L. Wu, and D. DiMaio. 2003. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77:1551-1563.
15. del Mar Pena, L. M., and L. A. Laimins. 2001. Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J. Virol. 75:10005-10013.
16. Dong, G., T. R. Broker, and L. T. Chow. 1994. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol. 68:1115-1127.
17. El Awady, M. K., J. B. Kaplan, S. J. O'Brien, and R. D. Burk. 1987. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159:389-398.
18. Everett, R. D. 2001. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20:7266-7273.
19. Fey, E. G., G. Krochmalnic, and S. Penman. 1986. The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy. J. Cell Biol. 102:1654-1665.
20. Gall, J. G. 2000. Cajal bodies: the first 100 years. Annu. Rev. Cell Dev. Biol. 16:273-300.
21. Hurlin, P. J., P. Kaur, P. P. Smith, N. Perez-Reyes, R. A. Blanton, and J. K. McDougall. 1991. Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc. Natl. Acad. Sci. USA 88:570-574.
22. Jensen, K., C. Shiels, and P. S. Freemont. 2001. PML protein isofonns and the RBCC/TRIM motif. Oncogene 20:7223-7233.
23. Jeon, S., and P. F. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
24. Johnson, C. V., R. H. Singer, and J. B. Lawrence. 1991. Fluorescent detection of nuclear RNA and DNA: implications for genome organization. Methods Cell Biol. 35:73-99.
25. Juttermann, R., E. Li, and R. Jaenisch. 1994. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 91:11797-11801.
26. Klaes, R., S. M. Woener, R. Ridder, N. Wentzensen, M. Düerst, A. Schneider, B. Lotz, P. Melsheimer, and M. von Knebel Doeberitz. 1999. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59:6132-6136.
27. Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:198-209.
28. Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
29. List, H. J., V. Patzel, U. Zeidler, A. Schopen, G. Ruhl, J. Stollwerk, and G. Klock. 1994. Methylation sensitivity of the enhancer from the human papillomavirus type 16. J. Biol. Chem. 269:11902-11911.
30. Liu, H. T., and B. Y. Yung. 1999. In vivo interaction of nucleophosmin/B23 and protein C23 during cell cycle progression in HeLa cells. Cancer Lett. 144:45-54.
31. Ma, T., B. A. Van Tine, Y. Wei, M. D. Garrett, D. Nelson, P. D. Adams, J. Wang, J. Qin, L. T. Chow, and J. W. Harper. 2000. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev. 14:2298-2313.
32. McClintock, B. 1951. Chromosome organization and genie expression. Cold Spring Harbor Symposia Quant. Biol. 16:13-47.
33. Mincheva, A., L. Gissmann, and H. zur Hausen. 1987. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med. Microbiol. Immunol. 176:245-256.
34. Misteli, T. 2001. Protein dynamics: implications for nuclear architecture and gene expression. Science 291:843-847.
35. Moen, P. T., K. P. Smith, and J. B. Lawrence. 1995. Compartmentalization of specific pre-mRNA metabolism: an emerging view. Hum. Mol. Gen. 4:1779-1789.
36. Montgomery, K. D., K. L. Tedford, and J. K. McDougall. 1995. Genetic instability of chromosome 3 in HPV-immortalized and tumorigenic human keratinocytes, Genes Chromosomes Cancer 14:97-105.
37. Münger, K. 2002. The role of human papillomaviruses in human cancers. Front. Biosci. 7:641-649.
38. Münger, K., and P. M. Howley. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213-228.
39. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
40. Parker, J. N., W. Zhao, K. J. Askins, T. R. Broker, and L. T. Chow. 1997. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ. 8:751-762.
41. Pater, M. M., and A. Pater. 1985. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145:313-318.
42. Rajkumar, T., and W. J. Gullick. 1994. The type I growth factor receptors in human breast cancer. Breast Cancer Res. Treat. 29:3-9.
43. Rhee, I., K. E. Bachman, B. H. Park, K. W. Jair, R. W. Yen, K. E. Schuebel, H. Cui, A. P. Feinberg, C. Lengauer, K. W. Kinzler, S. B. Baylin, and B. Vogelstein. 2002. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416:552-556.
44. Romanczuk, H., F. Thierry, and P. M. Howley. 1990. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64:2849-2859.
45. Rosl, F., A. Arab, B. Klevenz, and H. zur Hausen. 1993. The effect of DNA methylation on gene regulation of human papillomaviruses. J. Gen. Virol. 74:791-801.
46. Salomoni, P., and P. P. Pandolfi. 2002. The role of PML in tumor suppression. Cell 108:165-170.
47. Santi, D. V., C. E. Garrett, and P. J. Barr. 1983. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 33: 9-10.
48. Schneider-Gädicke, A., and E. Schwarz. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
49. Schwab, M. 1993. Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Semin. Cancer Biol. 4:13-18.
50. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
51. Smith, K. P., P. T. Moen, K. L. Wydner, J. R. Coleman, and J. B. Lawrence. 1999. Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific. J. Cell Biol. 22:617-629.
52. Smits, H. L., M. T. Cornelissen, M. F. Jebbink, J. G. van den Tweel, A. P. Struyk, M. Briet, and J. ter Schegget. 1991. Human papillomavirus type 16 transcripts expressed from viral-cellular junctions and full-length viral copies in CaSki cells and in a cervical carcinoma. Virology 182:870-873.
53. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680-4684.
54. Solinas-Toldo, S., M. Dürst, and P. Lichter. 1997. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. Proc. Natl. Acad. Sci. USA 94:3854-3859.
55. Spector, D. L. 1993. Macromolecular domains within the cell nucleus. Annu. Rev. Cell Biol. 9:265-315.
56. Spector, D. L. 2001. Nuclear domains. J. Cell Sci. 114:2891-2893.
57. Steenbergen, R. D., M. A. Hermsen, J. M. Walboomers, G. A. Meijer, J. P. Baak, C. J. Meyer, and P. J. Snijders. 1998. Non-random allelic losses at 3p, 11p, and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes. Int. J. Cancer 73:412-417.
58. Steenbergen, R. D., J. N. Parker, S. Isern, P. J. Snijders, J. M. Walboomers, C. J. Meijer, T. R. Broker, and L. T. Chow. 1998. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes. J. Virol. 72:749-757.
59. Steenbergen, R. D., J. M. Walboomers, C. J. Meger, E. M. van der Raaij-Helmer, J. N. Parker, L. T. Chow, T. R. Broker, and P. J. Snijders. 1996. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes toward immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 13:1249-1257.
60. Stoler, M. H., C. R. Rhodes, A. Whitbeck, S. M. Wolinsky, L. T. Chow, and T. R. Broker. 1992. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23:117-128.
61. Stoler, M. H., S. M. Wolinsky, A. Whitbeck, T. R. Broker, and L. T. Chow. 1989. DifferentiatioN-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340.
62. Swindle, C. S., N. Zou, B. A. Van Tine, G. M. Shaw, J. A. Engler, and L. T. Chow. 1999. HPV-11 DNA replication compartments in a transient DNA replication system. J. Virol. 73:1001-1009.
63. Tan, S. H., L. E. Leong, P. A. Walker, and H. U. Bernard. 1994. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68:6411-6420.
64. Van Tine, B. A., L. D. Dao, S.-Y. Wu, T. M. Sonbuchner, B.-Y. Lin, N. Zou, C.-M. Chiang, T. R. Broker, and L. T. Chow. 2004. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc. Natl. Acad. Sci. USA 101:4030-4035.
65. Van Tine, B. A., J. F. Knops, A. Butler, P. Deloukas, G. M. Shaw, and P. H. King. 1998. Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique. Genomics 53:296-299.
66. Wei, X., J. M. Decker, H. Liu, Z. Zhang, R. B. Arani, J. M. Kilby, M. S. Saag, X. Wu, G. M. Shaw, and J. C. Kappes. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
67. CIP-dependent pathways. EMBO J. 19:5762-5771.
68. Wentzensen, N., R. Kidder, R. Klaes, S. Vinokurova, U. Schaefer, and M. K. Doeberitz. 2002. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and -18 positive anogenital lesions. Oncogene 21:419-426.
69. Xing, Y., C. V. Johnson, P. T. Moen, J. A. McNeil, and J. Lawrence. 1995. J. Nonrandom gene organization: structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains. J. Cell Biol. 131: 1635-1647.
70. Yee, C., I. Krishnan-Hewlett, C. C. Baker, R. Schlegel, and P. M. Howley. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell. Am. J. Pathol. 119:361-366.
71. Zhao, J., B. K. Kennedy, B. D. Lawrence, D. A. Barbie, A. G. Matera, J. A. Fletcher, and E. Harlow. 2000. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 14:2283-2297.
72. Zhao, W., F. Noya, W. Y. Chen, T. M. Townes, L. T. Chow, and T. R. Broker. 1999. Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. J. Virol. 73:5026-5033.
73. zur Hausen, H. 1999. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin. Cancer Biol. 1. 9:405-411.